CTNNB1 and desmoid tumor: We next aimed to study the expression of our candidate surface marker in situ. First, we performed double immunofluorescent staining for CD142 and PDPN in a human desmoid tumor biopsy showing high and low beta-catenin staining regions (Fig. 3C).